How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial

Long-term treatment with angiotensin-converting enzyme inhibitors reduces post-infarction morbidity and mortality in patients with left ventricular (LV) systolic dysfunction or symptomatic heart failure. Until recently, the effect of such treatment in patients with preserved LV function has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonarjee, Vernon VS, Dickstein, Kenneth
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59642/
https://www.ncbi.nlm.nih.gov/pubmed/11806788
http://dx.doi.org/10.1186/cvm-2-4-151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59642/
https://www.ncbi.nlm.nih.gov/pubmed/11806788
http://dx.doi.org/10.1186/cvm-2-4-151

Ejemplares similares